Literature DB >> 27717264

Carving depression at its joints?

Allan H Young1, Alessandro Colasanti1.   

Abstract

Entities:  

Year:  2016        PMID： 27717264      PMCID： PMC5032503          DOI： 10.1002/wps.20367

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  10 in total

1.  Antidepressants for major depressive episodes: a modest proposal.

Authors:  Allan H Young
Journal:  Aust N Z J Psychiatry       Date:  2012-04       Impact factor: 5.744

2.  Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the BRIDGE study.

Authors:  Jules Angst; Jean-Michel Azorin; Charles L Bowden; Giulio Perugi; Eduard Vieta; Alex Gamma; Allan H Young
Journal:  Arch Gen Psychiatry       Date:  2011-08

Review 3.  Molecular biomarkers of depression.

Authors:  Anand Gururajan; Gerard Clarke; Timothy G Dinan; John F Cryan
Journal:  Neurosci Biobehav Rev       Date:  2016-02-21       Impact factor: 8.989

4.  The classification of depressive illnesses.

Authors:  R E Kendell
Journal:  Scott Med J       Date:  1978-01       Impact factor: 0.729

5.  Problems in the classification of affective disorders.

Authors:  M Roth
Journal:  Acta Psychiatr Scand Suppl       Date:  1981

6.  Abandoning personalization to get to precision in the pharmacotherapy of depression.

Authors:  Roy H Perlis
Journal:  World Psychiatry       Date:  2016-10       Impact factor: 49.548

7.  High levels of serotonin transporter occupancy with low-dose clomipramine in comparative occupancy study with fluvoxamine using positron emission tomography.

Authors:  Tetsuya Suhara; Akihiro Takano; Yasuhiko Sudo; Tetsuya Ichimiya; Makoto Inoue; Fumihiko Yasuno; Yoko Ikoma; Yoshiro Okubo
Journal:  Arch Gen Psychiatry       Date:  2003-04

Review 8.  Lithium response across generations.

Authors:  P Grof; A Duffy; M Alda; T Hajek
Journal:  Acta Psychiatr Scand       Date:  2009-11       Impact factor: 6.392

9.  Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.

Authors:  Trisha Suppes; Robert Silva; Josephine Cucchiaro; Yongcai Mao; Steven Targum; Caroline Streicher; Andrei Pikalov; Antony Loebel
Journal:  Am J Psychiatry       Date:  2015-11-10       Impact factor: 18.112

Review 10.  Genetics of Alzheimer's disease.

Authors:  Rita Guerreiro; John Hardy
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620
  10 in total
  1 in total

1.  News from WPA Scientific Sections.

Authors:  Afzal Javed
Journal:  World Psychiatry       Date:  2017-06       Impact factor: 49.548
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.